Treatment of Metastatic Breast Carcinoma Refractory to Doxorubicin with Liposomal-Annamycin

Abstract

We studied the toxicity and antitumor activity of Liposomal/Annamycin in patients with metastatic breast carcinoma. Sixteen patients have been treated. Toxicity was mild and consisted mostly of bone marrow suppression, particularly granulocytopenia. Non hermatological toxicity was less than what is usually seen with other anthracyclines. No responses have been seen. The study is continuing accruing a total of 12 additional less heavily retreated patients

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2000
Accession Number
ADA389581

Entities

People

  • Aysegul A. Sahin

Organizations

  • The University of Texas MD Anderson Cancer Center

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Anatomy
  • Biological Sciences
  • Biomedical Research
  • Bone Marrow
  • Breast Cancer
  • Carcinoma
  • Chemotherapy
  • Classification
  • Diseases And Disorders
  • Electronic Mail
  • Neoplasms
  • Skin And Connective Tissue Diseases
  • Skin Diseases
  • Therapy
  • Toxicity

Fields of Study

  • Medicine

Readers

  • Clinical Trial Research.
  • Oncology (Cancer Research).